DePuy Synthes’ Gains Offset by Currency Headwinds

DePuy Synthes reported 3Q22 orthopedic sales of $2,094.7 million, +0.1% compared to 3Q21. However, when adjusted for foreign currency headwinds, the company grew +4.7% for the quarter.

The company attributed the strong sales quarter to procedure recovery and its VELYS digital solutions.

"We are seeing procedures recovering. We posted a...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us